Precision Medicine in Control of Visceral Leishmaniasis Caused by L. donovani
Precision medicine and precision global health in visceral leishmaniasis (VL) have not yet been described and could take into account how all known determinants improve diagnostics and treatment for the individual patient. Precision public health would lead to the right intervention in each VL endem...
Saved in:
Main Author: | Eduard E. Zijlstra |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/379b6f9beb104eb79b65e6f37d4d87fc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Visceral leishmaniasis and HIV coinfection: current perspectives
by: Lindoso JAL, et al.
Published: (2018) -
Hepatomegaly Associated with Non-Obstructive Sinusoidal Dilation in Experimental Visceral Leishmaniasis
by: Kota Maeda, et al.
Published: (2021) -
Pediatric visceral leishmaniasis in Tartous, Syria
by: Ali Othman Hamwi, et al.
Published: (2020) -
Magnitude of visceral leishmaniasis and poor treatment outcome among HIV patients: meta-analysis and systematic review
by: Alemayehu M, et al.
Published: (2016) -
Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis
by: Want MY, et al.
Published: (2017)